Your SlideShare is downloading. ×
Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012

100
views

Published on


0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
100
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Left Ventricular Dysfunction Global Clinical Trials Review, H2,2012Report Details:Published:November 2012No. of Pages: 97Price: Single User License – US$2500Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012SummaryGlobalDatas clinical trial report, “Left Ventricular Dysfunction Global Clinical Trials Review, H2,2012" provides data on the Left Ventricular Dysfunction clinical trial scenario. This report provideselemental information and data relating to the clinical trials on Left Ventricular Dysfunction. Itincludes an overview of the trial numbers and their recruitment status as per the site of trialconduction across the globe. The databook offers a preliminary coverage of disease clinical trialsby their phase, trial status, prominence of the sponsors and also provides briefing pertaining to thenumber of trials for the key drugs for treating Left Ventricular Dysfunction. This report is built usingdata and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability andrelevance of data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and Central America,Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, alongwith the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited andsponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner
  • 2. - Abridged view of the performance of the trials in terms of their status, recruitment, location,sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesGet your copy of this report @http://www.reportsnreports.com/reports/210606-left-ventricular-dysfunction-global-clinical-trials-review-h2-2012.htmlMajor points covered in Table of Contents of this report includeTable of ContentsTable of Contents 2List of Tables 5List of Figures 6Introduction 7Left Ventricular Dysfunction 7Report Guidance 7Clinical Trials by Region 8Clinical Trials by Country 9Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11Top Five Countries Contributing to Clinical Trials in Europe 12Top Countries Contributing to Clinical Trials in North America 13Top Countries Contributing to Clinical Trials in Middle East and Africa 14Top Countries Contributing to Clinical Trials in Central and South America 15Clinical Trials by BRIC Nations 16Clinical Trials by G7 Nations 17Clinical Trials in G7 Nations by Trial Status 18Clinical Trials by E7 Nations 19Clinical Trials in E7 Nations by Trial Status 20Clinical Trials by Phase 21In Progress Trials by Phase 22Clinical Trials by Trial Status 23Unaccomplished Trials of Left Ventricular Dysfunction 24Subjects Recruited Over a Period of Time 26Prominent Sponsors 27Top Companies Participating in Left Ventricular Dysfunction Therapeutics Clinical Trials 29Prominent Drug Comparison 31Clinical Trial Profiles 32Clinical Trial Overview of Top Companies 32Amgen Inc. 32Clinical Trial Overview of Amgen Inc. 32Bayer AG 33Clinical Trial Overview of Bayer AG 33
  • 3. Pfizer Inc. 34Clinical Trial Overview of Pfizer Inc. 34AstraZeneca PLC 35Clinical Trial Overview of AstraZeneca PLC 35ASKLEPIOS proresearch Klinische Forschung und Entwicklung 36Clinical Trial Overview of ASKLEPIOS proresearch Klinische Forschung und Entwicklung 36Solvotrin Innovations Ltd 37Clinical Trial Overview of Solvotrin Innovations Ltd 37Menarini Laboratories International Operations Luxembourg S.A 38Clinical Trial Overview of Menarini Laboratories International Operations Luxembourg S.A 38GlaxoSmithKline LLC 39Clinical Trial Overview of GlaxoSmithKline LLC 39ARCA biopharma, Inc. 40Clinical Trial Overview of ARCA biopharma, Inc. 40Capricor Inc. 41Clinical Trial Overview of Capricor Inc. 41ResMed SAS 42Clinical Trial Overview of ResMed SAS 42Medtronic CardioVascular 43Clinical Trial Overview of Medtronic CardioVascular 43Cytokinetics, Incorporated 44Clinical Trial Overview of Cytokinetics, Incorporated 44Sanofi 45Clinical Trial Overview of Sanofi 45Mylan Inc. 46Clinical Trial Overview of Mylan Inc. 46Astellas Pharma Inc. 47Clinical Trial Overview of Astellas Pharma Inc. 47Acorda Therapeutics, Inc. 48Clinical Trial Overview of Acorda Therapeutics, Inc. 48Merck & Co., Inc. 49Clinical Trial Overview of Merck & Co., Inc. 49Biotronik SE & Co. KG 50Clinical Trial Overview of Biotronik SE & Co. KG 50Medtronic, Inc. 51Clinical Trial Overview of Medtronic, Inc. 51Clinical Trial Overview of Top Universities / Institutes / Hospitals 52University Health Network 52Clinical Trial Overview of University Health Network 52University of Ottawa Heart Institute 53Clinical Trial Overview of University of Ottawa Heart Institute 53Kyoto University 54
  • 4. Clinical Trial Overview of Kyoto University 54Imperial College London 55Clinical Trial Overview of Imperial College London 55Kyoto Prefectural University of Medicine 56Clinical Trial Overview of Kyoto Prefectural University of Medicine 56Xijing Hospital 57Clinical Trial Overview of Xijing Hospital 57VU University Medical Center 58Clinical Trial Overview of VU University Medical Center 58Sheba Medical Center 59Clinical Trial Overview of Sheba Medical Center 59MetroHealth Medical Center 60Clinical Trial Overview of MetroHealth Medical Center 60Weill Cornell Medical College 61Clinical Trial Overview of Weill Cornell Medical College 61Emory University 62Clinical Trial Overview of Emory University 62Cedars-Sinai Medical Center 63Clinical Trial Overview of Cedars-Sinai Medical Center 63University of Miami 64Clinical Trial Overview of University of Miami 64Charles University 65Clinical Trial Overview of Charles University 65University Hospital Basel 66Clinical Trial Overview of University Hospital Basel 66University of Pennsylvania 67Clinical Trial Overview of University of Pennsylvania 67RWTH Aachen University 68Clinical Trial Overview of RWTH Aachen University 68Washington University School of Medicine 69Clinical Trial Overview of Washington University School of Medicine 69Assistance Publique - Hopitaux de Paris 70Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 70Rabin Medical Center 71Clinical Trial Overview of Rabin Medical Center 71Five Key Clinical Profiles 72Appendix 94Abbreviations 94Definitions 94Research Methodology 95Secondary Research 96About GlobalData 96
  • 5. Contact Us 96Disclaimer 96Source 97List of TablesLeft Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by TopCountries, 2012* 10Left Ventricular Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*11Left Ventricular Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12Left Ventricular Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2012* 13Left Ventricular Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries,2012* 14Left Ventricular Dysfunction Therapeutics Clinical Trials, Central and South America, TopCountries, 2012* 15Left Ventricular Dysfunction Therapeutics Clinical Trials, BRIC Countries, 2012* 16Left Ventricular Dysfunction Therapeutics Clinical Trials, G7 Countries, 2012* 17Left Ventricular Dysfunction Therapeutics Market, G7 Countries, Clinical Trials by Trial Status,2012* 18Left Ventricular Dysfunction Therapeutics Clinical Trials, E7 Countries, 2012* 19Left Ventricular Dysfunction Therapeutics Market, E7 Countries, Clinical Trials by Trial Status,2012* 20Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Phase2012* 22Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23Left Ventricular Dysfunction Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 24Left Ventricular Dysfunction Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment TargetTrends, 2006-2011 26Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*30Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Clinical Trials by ProminentDrugs, 2012* 31Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by AmgenInc., 2012* 32Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by BayerAG, 2012* 33Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer
  • 6. Inc., 2012* 34Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byAstraZeneca PLC, 2012* 35Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byASKLEPIOS proresearch Klinische Forschung und Entwicklung, 2012* 36Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by SolvotrinInnovations Ltd, 2012* 37Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by MenariniLaboratories International Operations Luxembourg S.A, 2012* 38Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byGlaxoSmithKline LLC, 2012* 39Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCAbiopharma, Inc., 2012* 40Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by CapricorInc., 2012* 41Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by ResMedSAS, 2012* 42Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byMedtronic CardioVascular, 2012* 43Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byCytokinetics, Incorporated, 2012* 44Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi,2012* 45Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by MylanInc., 2012* 46Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by AstellasPharma Inc., 2012* 47Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by AcordaTherapeutics, Inc., 2012* 48Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck &Co., Inc., 2012* 49Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by BiotronikSE & Co. KG, 2012* 50Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byMedtronic, Inc., 2012* 51Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byUniversity Health Network, 2012* 52Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byUniversity of Ottawa Heart Institute, 2012* 53Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by KyotoUniversity, 2012* 54Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial
  • 7. College London, 2012* 55Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by KyotoPrefectural University of Medicine, 2012* 56Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by XijingHospital, 2012* 57Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by VUUniversity Medical Center, 2012* 58Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by ShebaMedical Center, 2012* 59Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byMetroHealth Medical Center, 2012* 60Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by WeillCornell Medical College, 2012* 61Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by EmoryUniversity, 2012* 62Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2012* 63Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byUniversity of Miami, 2012* 64Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by CharlesUniversity, 2012* 65Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byUniversity Hospital Basel, 2012* 66Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byUniversity of Pennsylvania, 2012* 67Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by RWTHAachen University, 2012* 68Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byWashington University School of Medicine, 2012* 69Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials byAssistance Publique - Hopitaux de Paris, 2012* 70Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by RabinMedical Center, 2012* 71List of FiguresLeft Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by TopCountries, 2012* 10Left Ventricular Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%),2012* 11Left Ventricular Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
  • 8. 12Left Ventricular Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2012*13Left Ventricular Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries(%), 2012* 14Left Ventricular Dysfunction Therapeutics Clinical Trials, Central and South America, TopCountries (%), 2012* 15Left Ventricular Dysfunction Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16Left Ventricular Dysfunction Therapeutics Clinical Trials, G7 Countries (%), 2012* 17Left Ventricular Dysfunction Therapeutics Market, G7 Countries, Clinical Trials by Trial Status,2012* 18Left Ventricular Dysfunction Therapeutics Clinical Trials, E7 Countries (%), 2012* 19Left Ventricular Dysfunction Therapeutics Market, E7 Countries, Clinical Trials by Trial Status,2012* 20Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Phase,2012* 22Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment TargetTrends, 2006-2011 26Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*29Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Clinical Trials by ProminentDrugs, 2012* 31GlobalData Methodology 95Contact: sales@reportsandreports.com for more information.